Jumping into the vaccine gold mine... or landmine?


In July, the government had agreed for the facilities owned by Pharmaniaga Bhd and Duopharma Biotech Bhd to be used for the fill and finish process of the Covid-19 vaccine.

THE latest buzzword in the market now is vaccine, amid all the fanfare surrounding rubber glove makers who have been enjoying a spectacular run in the coronavirus disease (Covid-19) race.

If there is something that will stop the dominance of rubber gloves in their tracks it will have to be the development of a vaccine.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
vaccine , distribution , Duopharma , NRPA , Pharmaniaga , Covid-19 ,

Next In Business News

POWERING ASEAN’S DIGITAL GROWTH
Indonesia MSCI alert sends ripples to Malaysia
Turning footfall into higher profits
Eco Business Park 8 first look signals new industrial opportunities in JS-SEZ
Wawasan Dengkil unit enters 25-year sublease for solar plant site
ICT Zone Asia secures RM23.82mil hardware deal
Fire hits Kumpulan Jetson subsidiary’s Port Klang factory
SDS Group’s London Bakery acquires 14.32 ha in Johor for RM101.7mil
Carlo Rino eyes Main Market transfer by 2H26
MTAG unit proposes RM53.6mil land acquisition in Tebrau

Others Also Read